摘要
多囊卵巢综合征(PCOS)是常见的妇科内分泌疾病,以高雄激素表现、持续无排卵、卵巢多囊样改变为特征,易导致育龄妇女不孕。PCOS病因尚不清楚,肥胖等代谢相关性疾病与PCOS关系密切。生活方式干预是PCOS的首选基础治疗,减重是有效的治疗措施。与传统饮食相比,生酮饮食能够较快降低体质量。基于《生酮饮食干预多囊卵巢综合征中国专家共识(2018年版)》及既往相关研究成果,本研究制订《多囊卵巢综合征的生酮治疗临床路径》,为PCOS的生酮治疗提供临床标准。
Polycystic ovary syndrome(PCOS)is a common gynecological endocrine disease,which is characterized by hyperandrogen,persistent anovulation and polycystic ovarian changes,and it can easily lead to infertility in women with childbearing age.The etiology of PCOS is still unclear,and obesity and otheRmetabolic diseases are closely related to PCOS.Lifestyle intervention is the preferred basic treatment foRPCOS,and weight loss is an effective therapeutic method.Compared with the traditional diet,ketogenic diet can rapidly reduce body weight.Based on the Chinese expert consensus of ketogenic diet intervention in polycystic ovary syndrome(2018)and previous relevant research results,this study formulates the clinical pathway of ketogenic diet in the treatment of patients with polycystic ovary syndrome in ordeRto provide clinical standards foRthe ketogenic treatment of PCOS.
作者
陈海霞
李健
吴凤云
白栎然
顾蓓
宋晓红
孙宇
崔广霞
王子君
王小雪
尹聪
杨慕坤
范丽
白文佩
江波
CHEN Haixia;LI Jian;WU Fengyun;BAI Yueran;GU Bei;SONG Xiaohong;SUN Yu;CUI Guangxia;WANG Zijun;WANG Xiaoxue;YIN Cong;YANG Mukun;FAN Li;BAI Wenpei;JIANG Bo(Department of Gynecology,Beijing Shijitan Hospital Affiliated to Capital Medical University,Beijing,100038;Department of Gynecology,Beijing Hui Nationality Hospital,Beijing,100053;Nutritional Department,General Hospital of Aviation,Beijing,100012;Clinical Nutrition Department,Children′s Hospital Affiliated to Chongqing Medical University,Chongqing,400014;Department of Neuro-Onoclogy,Beijing Tiantan Hospital Affiliated to Capital Medical University,Beijing,100050)
出处
《实用临床医药杂志》
CAS
2021年第3期5-7,32,共4页
Journal of Clinical Medicine in Practice
基金
北京市医院管理中心“登峰”计划专项经费资助项目(DFL20190701)
北京市自然科学基金资助项目(7202075)
北京市医院管理中心临床医学发展专项经费资助项目(ZYLX202112)。
关键词
多囊卵巢综合征
生酮治疗
临床路径
高雄激素
卵巢多囊样改变
polycystic ovary syndrome
ketogenic therapy
clinical pathway
hyperandrogen
polycystic ovarian changes